Arthritis & Rheumatism

Anifrolumab shows long-term promise in patients with lupus

Type I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the ...

Diseases, Conditions, Syndromes

Monthly COVID-19 hospitalization rates peaked in December 2020

(HealthDay)—For adults hospitalized with COVID-19, monthly rates of hospitalization, intensive care unit (ICU) admission, and death peaked in December 2020, according to a study published online Aug. 10 in the Annals of ...

Medications

Antibiotics, corticosteroids beneficial in COPD exacerbations

(HealthDay)—For adults with exacerbation of chronic obstructive pulmonary disease (COPD), antibiotics and systemic corticosteroids are associated with less treatment failure, according to a review published online Feb. ...

page 1 from 3